BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 75503)

  • 1. HLA and Graves' disease or diabetes mellitus in Japan.
    Sasazuki T; Kohno Y; Iwamoto I; Kosaka K; Okimoto K; Maruyama H; Ishiba S; Konishi J; Takeda Y; Naito S
    N Engl J Med; 1978 Mar; 298(11):630-1. PubMed ID: 75503
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of glyoxalase I allotypes with Graves' disease and diabetes mellitus.
    Moens H; Payne R; Carter ND; Farid NR
    Hum Hered; 1980; 30(1):62-4. PubMed ID: 6892568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A negative association of HLA-BW52 with Graves' disease and insulin-dependent diabetes mellitus with juvenile onset among Japanese population.
    Kawa A; Nakamura S; Kono Y; Maeda Y; Kanehisa T
    Experientia; 1979 Apr; 35(4):547-8. PubMed ID: 582031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.
    Kusaka I; Nagasaka S; Fujibayashi K; Hayashi H; Kawakami A; Nakamura T; Rokkaku K; Saito T; Higashiyama M; Honda K; Ishikawa S; Saito T
    Endocr J; 1999 Dec; 46(6):747-54. PubMed ID: 10724349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human major histocompatibility complex and endocrine disease.
    Farid NR; Bear JC
    Endocr Rev; 1981; 2(1):50-86. PubMed ID: 7028471
    [No Abstract]   [Full Text] [Related]  

  • 6. The HLA system, autoimmune endocrinopathy and diabetes mellitus.
    Cudworth AG
    Eur J Clin Invest; 1978 Dec; 8(6):355-7. PubMed ID: 105906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symposium on major histocompatibility antigens (HLA) and diseases. Supplement: HLA system in Japanese patients with diabetes or Graves's disease].
    Kawa A
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1416-8. PubMed ID: 583284
    [No Abstract]   [Full Text] [Related]  

  • 8. HL-A in Graves' disease and in diabetes mellitus insulin-dependent.
    Seignalet J; Mirouze J; Jaffiol C; Selam JL; Lapinski H
    Tissue Antigens; 1975 Oct; 6(4):272-4. PubMed ID: 1242826
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
    Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
    Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.
    Uno H; Sasazuki T; Tamai H; Matsumoto H
    Nature; 1981 Aug; 292(5825):768-70. PubMed ID: 6894965
    [No Abstract]   [Full Text] [Related]  

  • 11. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
    Farid NR; Barnard JM; Marshall WH
    Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-BW35 and B5 in Japanese patients with Graves' disease.
    Kawa A; Nakamura S; Nakazawa M; Sakaguchi S; Kawabata T; Maeda Y; Kanehisa T
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):754-7. PubMed ID: 579034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous occurrence of type 1 diabetes mellitus and Graves' disease: a report of two cases and a review of the literature.
    Mizokami T; Yamauchi A; Sato Y; Toyonaga M; Imoto H; Kojima H; Saji H; Nunoi K
    Intern Med; 2013; 52(22):2537-43. PubMed ID: 24240794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese.
    Onuma H; Ota M; Sugenoya A; Inoko H
    Hum Immunol; 1994 Mar; 39(3):195-201. PubMed ID: 8026987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA B w4/w6 diallelic system in Graves' disease.
    Farid NR; Barnard JM; Sampson L; Noel EP; Marshall WH
    Tissue Antigens; 1978 May; 11(5):394-8. PubMed ID: 581239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
    Huang SM; Wu TJ; Lee TD; Yang EK; Shaw CK; Yeh CC
    Tissue Antigens; 2003 Feb; 61(2):154-8. PubMed ID: 12694583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The operation of immunological networks in Graves' disease.
    Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
    Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.